OSCAR B GOODMAN MD PHD NPI 1568542108

NPI Details

Oscar B Goodman, MD PHD is a hematology and oncology internal medicine in Las Vegas, NV with 26 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Oscar B Goodman, MD PHD NPI is 1568542108. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Graduation Year:1999

The provider's business location address is:

9280 W SUNSET RD STE 100
LAS VEGAS, NV
ZIP 89148-861
Phone: (702) 952-1251
Fax: (702) 952-1242

The NPI 1568542108 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Folic acid level, serum (HCPCS:82746)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Red blood count, automated test (HCPCS:85045)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Nephelometry, test method using light (HCPCS:83883)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Testosterone (hormone) level, total (HCPCS:84403)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Protein measurement, serum (HCPCS:84165)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Vitamin d-3 level (HCPCS:82306)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Magnesium level (HCPCS:83735)
• Unclassified drugs (HCPCS:J3490)
• Urinalysis, manual test (HCPCS:81002)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Ct scan of chest without contrast (HCPCS:71250)
• Drawing of blood for a medical problem (HCPCS:99195)
• Collection of blood sample from implanted device (HCPCS:36591)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Homocysteine (amino acid) level (HCPCS:83090)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)

The enumeration date for this NPI number is 10/17/2006 and was last updated on 2/29/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: